Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

A Study of a Single Subcutaneous Dose of JNJ-26366821 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of a single subcutaneous (SC) dose of JNJ-26366821.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - JNJ-26366821

Participants will receive sterile solution of JNJ-26366821 subcutaneously (SC).

Drug - Placebo

Participants will receive sodium chloride injection as placebo on Day 1.

Additional Information

Official Study Title

A Randomized, Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of a Single Subcutaneous Dose of JNJ-26366821 in Healthy Volunteers

Clinical Trial ID

NCT03990519

ParticipAid ID

b82r3e